On Tuesday, Mural Oncology plc (NASDAQ: MURA) was 133.98% up from the session before settling in for the closing price of $1.03. A 52-week range for MURA has been $0.95 – $4.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 5.55% over the last five years. When this article was written, the company’s average yearly earnings per share was at 28.50%. With a float of $15.34 million, this company’s outstanding shares have now reached $17.10 million.
The firm has a total of 116 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mural Oncology plc (MURA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mural Oncology plc stocks. The insider ownership of Mural Oncology plc is 10.97%, while institutional ownership is 52.81%. The most recent insider transaction that took place on Mar 04 ’25, was worth 14,491. Before that another transaction happened on Mar 05 ’25, when Company’s insider sold 1,469 for $3.45, making the entire transaction worth $5,068. This insider now owns 73,564 shares in total.
Mural Oncology plc (MURA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.50% per share during the next fiscal year.
Mural Oncology plc (NASDAQ: MURA) Trading Performance Indicators
You can see what Mural Oncology plc (MURA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.58, a number that is poised to hit -2.04 in the next quarter and is forecasted to reach -2.76 in one year’s time.
Technical Analysis of Mural Oncology plc (MURA)
Analysing the last 5-days average volume posted by the [Mural Oncology plc, MURA], we can find that recorded value of 52.25 million was better than the volume posted last year of 3.93 million. As of the previous 9 days, the stock’s Stochastic %D was 34.23%. Additionally, its Average True Range was 0.37.
During the past 100 days, Mural Oncology plc’s (MURA) raw stochastic average was set at 38.52%, which indicates a significant decrease from 64.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 367.75% in the past 14 days, which was higher than the 214.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.0800, while its 200-day Moving Average is $3.3500. Now, the first resistance to watch is $3.0100. This is followed by the second major resistance level at $3.6100. The third major resistance level sits at $4.0100. If the price goes on to break the first support level at $2.0100, it is likely to go to the next support level at $1.6100. Now, if the price goes above the second support level, the third support stands at $1.0100.
Mural Oncology plc (NASDAQ: MURA) Key Stats
There are 17,228K outstanding shares of the company, which has a market capitalization of 41.53 million. As of now, sales total 0 K while income totals -128,510 K. Its latest quarter income was 0 K while its last quarter net income were -34,270 K.
